Streetbeat News

Equity Actions

SGH

SMART Global Holdings (NASDAQ: SGH) has received updated analyst ratings, indicating a positive outlook with an average 12-month price target of $27.12, reflecting an 8.48% increase from the previous target. Analysts from Needham and Stifel have maintained or raised their ratings, citing the company's solid revenue growth, impressive net margin, and effective asset utilization. Despite a high debt-to-equity ratio, SGH's financial health appears robust, with a notable performance in revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 12:00 pm

WES

Western Midstream (NYSE:WES) has received varied analyst ratings over the last three months, with a recent shift towards a more bullish outlook. Four analysts have updated their ratings, leading to an increase in the average 12-month price target to $35.75, up from $31.50. This reflects a 13.49% increase and is based on improved company performance and market conditions. Western Midstream, engaged in midstream energy assets, has shown notable revenue growth, a high net margin, and strong ROE and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 12:00 pm

AORT

Artivion (NYSE:AORT) has received consistent bullish ratings from 4 analysts over the past quarter, with a recent update showing an average 12-month price target of $25.5, marking a 10.87% increase from the previous target of $23. The company has shown impressive revenue growth of 17.98% as of December 31, 2023, and outperforms industry standards in net margin and ROE, despite challenges in debt management.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 12:00 pm

TDC

Analysts have varied opinions on Teradata (NYSE:TDC), with recent ratings ranging from bullish to bearish. Over the past quarter, sentiments have shifted, with a notable decline in the average 12-month price target from $55.62 to $49.11, reflecting a 11.7% decrease. Analyst actions include lowering and raising price targets, indicating a dynamic perception of Teradata's market position. Despite this, Teradata's financial performance shows challenges in revenue growth, profitability, and debt management compared to industry peers.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 12:00 pm

OGN

Organon (NYSE:OGN), a global healthcare company, announced a proposed offering of $1.0 billion in senior notes, split equally between secured and unsecured notes due 2034, in collaboration with its wholly-owned subsidiary, Organon Foreign Debt Co-Issuer B.V.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:59 am

ELDN

Eledon Pharmaceuticals' stock trades lower following the announcement of a $50 million oversubscribed private placement and clinical progress with tegoprubart for preventing transplant rejection.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:46 am

ML

MoneyLion expects Q2 2024 revenue to be between $125M-$130M, indicating a 17-22% growth compared to Q2 2023. The company also forecasts an Adjusted EBITDA of $17M-$20M, which would represent a margin of 13.1-16.0%, significantly higher than the 8.7% margin in Q2 2023.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:37 am

GTN

Gray Television's Board of Directors has authorized the use of up to $250 million of its available liquidity for the repurchase of its outstanding indebtedness, with this authorization valid through December 31, 2025.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:35 am

BP

EIPX

HJEN

BP PLC reported lower-than-expected first-quarter FY24 results, with sales of $48.88 billion missing the consensus of $55.08 billion and adjusted EBITDA declining to $10.3 billion from $13.1 billion a year ago. Hydrocarbons production decreased by 5.7% Y/Y, and net debt rose to $24.02 billion. Despite this, BP announced a dividend and completed $1.75 billion in share buybacks, expecting to buy back $3.5 billion in shares in the first half of 2024. The company's outlook for FY24 includes slightly higher reported and underlying upstream production and a capital expenditure of around $16 billion.

Portfolio Pulse from Lekha Gupta

May 07, 2024 | 11:34 am

HSDT

Helius Medical Technologies announced the pricing of a $6.4 million public offering, including 804,999 Class A common shares and 2,047,222 pre-funded warrants, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:29 am